Cardiovascular Surgery

This channel includes news and new technology innovations for cardiac surgery. This includes coronary bypass grafts, surgical valve replacements.

The LivaNova Heater-Cooler System 3T helps open heart surgery patients, but can pose an infection risk if not properly cared for.

The LivaNova Heater-Cooler System 3T helps open heart surgery patients, but can pose an infection risk if not properly cared for.

News | Cardiovascular Surgery | February 27, 2020

February 27, 2020 — The U.S. Food and Drug Administration (FDA) sent a safety communication this week to healthcare...

A 3-D reconstruction of a cardiac CT scan showing an implanted Medtronic CoreValve TAVR device. Imagine courtesy of TeraRecon. #TAVR #TAVI

A 3-D reconstruction of a cardiac CT scan showing an implanted Medtronic CoreValve TAVR device. Image courtesy of TeraRecon

Feature | Heart Valve Technology | February 24, 2020 | Dave Fornell, Editor

In August 2019, the U.S. Food and Drug Administration (FDA) expanded the indication for the use of transcatheter...

he U.S. Food and Drug Administration (FDA) has approved Carmat's investigational device exemption (IDE) application to start a U.S. early feasibility study (EFS) of its total artificial heart.
News | Heart Failure | February 12, 2020

February 12, 2020 — The U.S. Food and Drug Administration (FDA) has approved Carmat's investigational device...

Raj Makkar, M.D., led a multicenter national study comparing outcomes for minimally invasive heart valve replacement to open-heart surgery. Photo by Cedars-Sinai. TAVR performs as well as surgery for aortic valve replacement.

Raj Makkar, M.D., led a multicenter national study comparing outcomes for minimally invasive TAVR heart valve replacement to open-heart surgery. The study showed the two methods have similar outcomes. Photo by Cedars-Sinai.

News | Heart Valve Technology | January 31, 2020

January 31, 2020 — A new study from the ...

Mayo Clinic uses the Da Vinci surgical robot to perform minimally invasive mitral valve surgeries.
News | Robotic Systems | January 20, 2020

January 20, 2020 — Research has found that repairing the mitral valve earlier, before the mitral valve prolapse...

Congestive heart failure patient Dorothy Moore committed herself to cardiac rehabilitation and increasing the amount of exercise she did and was able to reverse her heart failure class. She was a patient at the DMC Sinai-Grace Hospital in Detroit.

Congestive heart failure patient Dorothy Moore committed herself to cardiac rehabilitation and increasing the amount of exercise she did and was able to reverse her heart failure class. She was a patient at the DMC Sinai-Grace Hospital in Detroit. 

News | Cardiac Rehabilitation | January 15, 2020

January 15, 2020 – Too few people covered by Medicare participated in outpatient cardiac rehabilitation after a...

Abbott announced U.S. Food and Drug Administration (FDA) approval of a new alternative surgical technique for Abbott's HeartMate 3 heart pump that will allow more advanced heart failure patients to avoid open heart surgery. The new, less invasive approach is designed to provide surgeons a choice in surgical method for patients receiving the HeartMate 3 Left Ventricular Assist Device (LVAD).
News | Ventricular Assist Devices (VAD) | January 07, 2020

January 7, 2020 — Abbott announced U.S. Food and Drug Administration (FDA) approval of a new alternative surgical...

People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes.  In early December 2019, leaders of the European Association for Cardiothoracic Surgery (EACTS) withdrew their support for European practice guidelines that endorse the use of coronary stents in many patients with left main coronary artery disease.

People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes.

News | Cath Lab | January 02, 2020 | Dave Fornell, Editor

January 2, 2020 — In early December 2019, leaders of the European...

The Wyss Translational Center in Zurich, Switzerland has developed the LifeMatrix platform to engineer tissues that can be implanted in patients and will grow with them. This technology is being developed for heart valves in younger patients to eliminate the need for repeat surgeries to implant larger prosthetic heart valves as the patient grows.

The Wyss Translational Center in Zurich, Switzerland has developed the LifeMatrix platform to engineer tissues that can be implanted in patients and will grow with them. This technology is being developed for heart valves in younger patients to eliminate the need for repeat surgeries to implant larger prosthetic heart valves as the patient grows.

 

News | Heart Valve Technology | December 26, 2019

While transcatheter heart valve replacement and repair devices are growing in popularity due to their delivery and...

CentriMag
News | Hemodynamic Support Devices | November 04, 2019

November 4, 2019 — Abbott is recalling its CentriMag Acute Circulatory Support System due to a calibration system...

A comparison of intravascular ultrasound (IVUS) vs. angiography found a significant mismatch and showed the benefits of IVUS in venous interventions.

A comparison of intravascular ultrasound (IVUS) vs. angiography found a significant mismatch and showed the benefits of IVUS in venous interventions.

News | Venous Therapies | October 31, 2019

October 31, 2019 – In a large series of iliac vein stent cases, a blinded comparison found...

Michigan Hospital Improves Post-CABG Outcomes Using Proactive Amiodarone Protocol
News | Cardiovascular Surgery | October 23, 2019

October 23, 2019 — Proactive administration of amiodarone to patients recovering from a common heart surgery shows...

Gore Block Grant Supports SVS Quality Programs
News | Cardiovascular Surgery | October 17, 2019

October 17, 2019 — W. L. Gore & Associates Inc. will support a new Society for Vascular Surgery (SVS) initiative...

A Sapien 3 TAVR valve in position as seen under GE Assist guidance on angiography. Study Finds Sustained Benefit for TAVR vs. SAVR at One Year. #TCT2019 #TCT19

A Sapien 3 TAVR valve in position as seen under GE Assist guidance on angiography.

News | Heart Valve Technology | October 04, 2019

October 4, 2019 – A new analysis of the PARTNER 3 Trial data found a modest, but significant, improvement in one-...

Overlay Init